Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTC
4.25
0.00 (0.00%)
Closed
Oct 6, 2026
Day's Range
4.254.25
52 wk Range
3.835.16
Financial Statements - HNSPF - Hansoh Pharmaceutical Group Company Limited
Revenue
15.02B▲ 22.6%
Net Income
5.55B▲ 27.1%Net Margin 37.0%
EBITDA
6.97B▲ 28.0%
Free Cash Flow
6.24B▲ 87.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 15.02B | 12.26B | 10.10B | 9.38B | 9.93B | 8.69B |
| Cost of Goods | 1.49B | 1.10B | 1.03B | 867.01M | 870.04M | 801.56M |
| Gross Profit | 13.53B | 11.15B | 9.07B | 8.51B | 9.06B | 7.88B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 5.54B | 4.03B | 2.83B | 2.79B | 3.03B | 2.83B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 6.55B | 5.08B | 3.76B | 2.94B | 3.30B | 3.09B |
| Income Tax | 995.12M | 713.35M | 488.65M | 364.68M | 587.18M | 529.39M |
| Net Income | 5.55B | 4.37B | 3.27B | 2.58B | 2.71B | 2.56B |
| EPS Basic | 0.93 | 0.74 | 0.55 | 0.44 | 0.46 | 0.44 |
| EPS Diluted | 0.93 | 0.73 | 0.52 | 0.44 | 0.44 | 0.44 |
| Basic Shares Outstanding | 5.96B | 5.93B | 5.92B | 5.91B | 43.04B | 42.70B |
| Diluted Shares Outstanding | 5.96B | 5.93B | 5.92B | 5.91B | 43.04B | 42.70B |
| Ebit | 6.55B | 5.09B | 3.83B | 3B | 3.35B | 3.09B |
| Ebitda | 6.97B | 5.45B | 4.06B | 3.28B | 3.65B | 3.29B |
| Net Income Continuous Operations | 6.55B | 5.08B | 3.76B | 2.94B | 3.30B | 3.09B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
